Blood markers may reveal why some women get repeat UTIs
NCT ID NCT03819712
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study aims to find blood biomarkers that predict recurrent urinary tract infections (UTIs) in women. Researchers will collect blood, urine, fecal, and vaginal samples from 109 healthy women aged 18–28, comparing those with a history of single versus recurrent cystitis. The goal is to understand how immune system differences may raise the risk of repeat infections, potentially leading to better prevention strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify women at high risk for recurrent UTIs and guide future research into better prevention or treatment.
What could go wrong
This is an observational study, not a treatment trial. It is small (109 participants) and only looks at biomarkers, so it won't directly change care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital de l'Archet 1 - CHU de Nice - Service d'Infectiologie
Nice, 06200, France